PHRX - Pharmagen, Inc. due diligence PHRX Company
Post# of 63696
Posted On: 12/10/2013 9:18:51 PM
PHRX - Pharmagen, Inc. due diligence
PHRX Company Description
Pharmagen, Inc. ("Pharmagen"), and wholly owned subsidiaries and operating divisions Pharmagen Laboratories, Inc., Pharmagen Distribution, LLC and Pharmagen Nutraceuticals, Inc. offers innovative solutions to the nations sterile pharmaceutical crisis. With a multi-solution approach, Pharmagen is helping to meet the demand of the health provider market through independent wholesale, compounding, and IT solutions. Nationally focused, Pharmagen is a distributor of specialty drugs, compounding and admix pharmacy and producer of over-the-counter ("OTC") branded multivitamins. Pharmagen currently functions as a just-in-time source of supply for hospitals for those products that are hard-to-find due to drug manufacturers' production shortages.
PHRX Products and Services
Divisions
Pharmagen Laboratories
Pharmagen Laboratories’ specialties include: urology, pain management, hormone replacement, ophthalmology, respiratory diseases, mental and psychological disorders, oncology, gynecology, muscular and skeletal locomotion (MS), trauma and burn units, neo-natal compounding, hypoallergenic compounding, and veterinary compounding. Pharmagen assists with projects designed to prevent, diagnose, and treat immune/autoimmune-related illnesses and emerging/re-emerging diseases.
Starting with USP and NF quality chemicals and nutraceuticals, the registered pharmacists at Pharmagen can compound a full range of dosage forms. Unlike most pharmacies, Pharmagen has its own Certified ISO Class 5 sterile environment, permitting onsite compounding of intravitreal injections, diagnostic agents, multi-dose and unit-dose injections, sterile preservative-free ophthalmic ointments, and other specialized medications.
Adhering to all USP <797> and USP <795> regulations covering both sterile and non-sterile drug manipulations, Pharmagen’s in house sterility, potency, and stability quality control systems are also validated by third party analytical testing laboratories, Eagle Analytical of Houston, Texas.
Pharmagen is dedicated to finishing each compounded medication in a timely manner. With a state-of-the-art compounding facility, and pharmacists dedicated to excellence, Pharmagen is a sole source pharmaceutical provider. Every compounded medication shipped is analyzed to ensure the end product meets the patient’s individual requirements.
Pharmagen Distribution
At Pharmagen Distribution, we are deeply committed to our clients and their success, and we take tremendous pride in our work. Our passion for excellence drives us to constantly strive toward exceeding the needs of our clients. Pharmagen is a national specialty pharmaceutical distribution company dedicated to servicing multi-specialty clinics, surgery centers, and physicians. Our product offerings include full-line brand pharmaceuticals, injectables, vaccines, and a highly competitive generics portfolio. We work directly with manufacturers as well as multiple suppliers, giving us the best network to source the products you need.
Through a dynamic, independent wholesale model, our team can supply almost any drug product in both small and large quantities including hard-to-find items. We can source branded, generic, and OTC products in all therapeutic classes and dosage forms. Lot and expiration date requirements are always followed. We have a proven track record shipping domestically and internationally to depots, clinical sites, sponsor companies, and clinical packagers around the globe.
Pharmagen offers a full line of products including plasma derivatives, oncology, women’s health, vaccines, surgical, and orthopedic.
Pharmagen Neutraceuticals
At Pharmagen Nutraceuticals, we manufacture and distribute over-the-counter (OTC) branded health supplements. Our innovative approach to OTC is to create suites of products designed to work in conjunction with prescription medications to alleviate side effects or prevent drug interactions. With an aging population, more Americans than ever rely on prescription medications. We are currently analyzing several OTC products that would allow us to become a powerful player in the multi-billion-dollar health supplement market.
Pharmagen’s first OTC product, Clotamin™, is available nationally at various retail outlets. Over 30 million prescriptions are written each year in the United States for Warfarin, an anticoagulant also known under many brand names including Coumadin™. Some pharmacists have been reluctant to recommend vitamin supplements to patients on blood thinners because of possible interactions with Warfarin therapy. Clotamin™ is the first product on the market that is designed to work in conjunction with anticoagulation therapy.
Licenses/ Accreditations
Pharmagen is licensed in Arkansas, Alaska, California, Colorado, Connecticut, Delaware, Washington, D.C., Georgia, Hawaii, Idaho, Illinois, Iowa, Kansas, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina,, Ohio, Oklahoma, Pennsylvania, Rhode Island, South Carolina, South Dakota, Texas, Utah, Vermont, Washington, West Virginia, and Wisconsin.
Accreditations & Memberships
North Carolina Biosciences Organization
PCAB Certification Pending
USP <797> Compliant Facility
USP <795> Compliant Facility
FDA Inspected
ISO Class 5 cleanrooms with Laminar Flow Hoods
Good Laboratory Practice Facility
D.E.A. Registration
PCCA Member in Good Standing
PHRX Key Company Management
Mackie Barch, CEO
Before launching Pharmagen, Mr. Barch cofounded Global Nutritional Research, manufacturers of over-the-counter (OTC) products for specific disease states based on Rx/OTC interaction. Since 2007, he has been involved in numerous financial and operational aspects of pharmaceutical companies operating in the secondary wholesale market. Prior to that, Mr. Barch worked in the financial services industry, where he was employed at Friedman, Billings, & Ramsey (FBR) from 2001 to 2006. He has participated in numerous equity offerings including 144a, IPO, and Secondary Offerings. He has extensive business experience and familiarity with a wide range of businesses and strategies in industries including Financial, Energy, Technology, Healthcare, and Consumer. He graduated from University of Colorado-Boulder with a BA in Economics. Barch is currently an elected official in the State of Maryland, serving as a City Council Member in Kensington, MD. Barch was President of the National Blood Clot Alliance Chapter in Washington, D.C., hosting charity events to raise awareness about the prevalence of thrombophilia and blood clot prevention.
Eric Clarke CFO
Mr. Clarke brings more than 17 years of extensive healthcare and financial expertise. Prior to joining Pharmagen, Clarke served as part of the leadership team at MedStar Health, a $4 billion diversified health system in the Washington, D.C. region, which includes leading medical facilities such as Washington Hospital Center and Georgetown University Hospital. As the leader in charge of the Internal Audit function, Clarke oversaw all financial and operational audits, was instrumental in building an effective internal audit function, and reported to the Audit and Compliance Committee. Prior to MedStar, Clarke served as Managing Director in charge of the Washington D.C., Risk Management Practice for a national professional services firm, providing expert advice and services in forensic accounting, SEC reporting, and Sarbanes-Oxley Compliance. Clarke has authored numerous presentations and articles in the accounting and compliance arena, and has been featured in several publications such as Compliance Week and Practical Accountant. As a member of the Virginia Society of Certified Public Accountants, Clarke holds a Master's degree in Accounting from George Washington University and a Bachelor's Degree from Wheaton College.
PHRX Contact Info
Pharmagen, Inc.
9337 Fraser Avenue
Silver Spring, MD 20910
Website: http://www.pharmageninc.com
Phone: 204-898-8160
Email: info@pharmagenrx.com
PHRX SEC Filings
http://www.otcmarkets.com/stock/PHRX/filings
PHRX Headlines
http://finance.yahoo.com/q/h?s=PHRX+Headlines
Investigate more about PHRX @ http://www.otcmarkets.com/stock/PHRX/quote for more due diligence.
PHRX Company Description
Pharmagen, Inc. ("Pharmagen"), and wholly owned subsidiaries and operating divisions Pharmagen Laboratories, Inc., Pharmagen Distribution, LLC and Pharmagen Nutraceuticals, Inc. offers innovative solutions to the nations sterile pharmaceutical crisis. With a multi-solution approach, Pharmagen is helping to meet the demand of the health provider market through independent wholesale, compounding, and IT solutions. Nationally focused, Pharmagen is a distributor of specialty drugs, compounding and admix pharmacy and producer of over-the-counter ("OTC") branded multivitamins. Pharmagen currently functions as a just-in-time source of supply for hospitals for those products that are hard-to-find due to drug manufacturers' production shortages.
PHRX Products and Services
Divisions
Pharmagen Laboratories
Pharmagen Laboratories’ specialties include: urology, pain management, hormone replacement, ophthalmology, respiratory diseases, mental and psychological disorders, oncology, gynecology, muscular and skeletal locomotion (MS), trauma and burn units, neo-natal compounding, hypoallergenic compounding, and veterinary compounding. Pharmagen assists with projects designed to prevent, diagnose, and treat immune/autoimmune-related illnesses and emerging/re-emerging diseases.
Starting with USP and NF quality chemicals and nutraceuticals, the registered pharmacists at Pharmagen can compound a full range of dosage forms. Unlike most pharmacies, Pharmagen has its own Certified ISO Class 5 sterile environment, permitting onsite compounding of intravitreal injections, diagnostic agents, multi-dose and unit-dose injections, sterile preservative-free ophthalmic ointments, and other specialized medications.
Adhering to all USP <797> and USP <795> regulations covering both sterile and non-sterile drug manipulations, Pharmagen’s in house sterility, potency, and stability quality control systems are also validated by third party analytical testing laboratories, Eagle Analytical of Houston, Texas.
Pharmagen is dedicated to finishing each compounded medication in a timely manner. With a state-of-the-art compounding facility, and pharmacists dedicated to excellence, Pharmagen is a sole source pharmaceutical provider. Every compounded medication shipped is analyzed to ensure the end product meets the patient’s individual requirements.
Pharmagen Distribution
At Pharmagen Distribution, we are deeply committed to our clients and their success, and we take tremendous pride in our work. Our passion for excellence drives us to constantly strive toward exceeding the needs of our clients. Pharmagen is a national specialty pharmaceutical distribution company dedicated to servicing multi-specialty clinics, surgery centers, and physicians. Our product offerings include full-line brand pharmaceuticals, injectables, vaccines, and a highly competitive generics portfolio. We work directly with manufacturers as well as multiple suppliers, giving us the best network to source the products you need.
Through a dynamic, independent wholesale model, our team can supply almost any drug product in both small and large quantities including hard-to-find items. We can source branded, generic, and OTC products in all therapeutic classes and dosage forms. Lot and expiration date requirements are always followed. We have a proven track record shipping domestically and internationally to depots, clinical sites, sponsor companies, and clinical packagers around the globe.
Pharmagen offers a full line of products including plasma derivatives, oncology, women’s health, vaccines, surgical, and orthopedic.
Pharmagen Neutraceuticals
At Pharmagen Nutraceuticals, we manufacture and distribute over-the-counter (OTC) branded health supplements. Our innovative approach to OTC is to create suites of products designed to work in conjunction with prescription medications to alleviate side effects or prevent drug interactions. With an aging population, more Americans than ever rely on prescription medications. We are currently analyzing several OTC products that would allow us to become a powerful player in the multi-billion-dollar health supplement market.
Pharmagen’s first OTC product, Clotamin™, is available nationally at various retail outlets. Over 30 million prescriptions are written each year in the United States for Warfarin, an anticoagulant also known under many brand names including Coumadin™. Some pharmacists have been reluctant to recommend vitamin supplements to patients on blood thinners because of possible interactions with Warfarin therapy. Clotamin™ is the first product on the market that is designed to work in conjunction with anticoagulation therapy.
Licenses/ Accreditations
Pharmagen is licensed in Arkansas, Alaska, California, Colorado, Connecticut, Delaware, Washington, D.C., Georgia, Hawaii, Idaho, Illinois, Iowa, Kansas, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina,, Ohio, Oklahoma, Pennsylvania, Rhode Island, South Carolina, South Dakota, Texas, Utah, Vermont, Washington, West Virginia, and Wisconsin.
Accreditations & Memberships
North Carolina Biosciences Organization
PCAB Certification Pending
USP <797> Compliant Facility
USP <795> Compliant Facility
FDA Inspected
ISO Class 5 cleanrooms with Laminar Flow Hoods
Good Laboratory Practice Facility
D.E.A. Registration
PCCA Member in Good Standing
PHRX Key Company Management
Mackie Barch, CEO
Before launching Pharmagen, Mr. Barch cofounded Global Nutritional Research, manufacturers of over-the-counter (OTC) products for specific disease states based on Rx/OTC interaction. Since 2007, he has been involved in numerous financial and operational aspects of pharmaceutical companies operating in the secondary wholesale market. Prior to that, Mr. Barch worked in the financial services industry, where he was employed at Friedman, Billings, & Ramsey (FBR) from 2001 to 2006. He has participated in numerous equity offerings including 144a, IPO, and Secondary Offerings. He has extensive business experience and familiarity with a wide range of businesses and strategies in industries including Financial, Energy, Technology, Healthcare, and Consumer. He graduated from University of Colorado-Boulder with a BA in Economics. Barch is currently an elected official in the State of Maryland, serving as a City Council Member in Kensington, MD. Barch was President of the National Blood Clot Alliance Chapter in Washington, D.C., hosting charity events to raise awareness about the prevalence of thrombophilia and blood clot prevention.
Eric Clarke CFO
Mr. Clarke brings more than 17 years of extensive healthcare and financial expertise. Prior to joining Pharmagen, Clarke served as part of the leadership team at MedStar Health, a $4 billion diversified health system in the Washington, D.C. region, which includes leading medical facilities such as Washington Hospital Center and Georgetown University Hospital. As the leader in charge of the Internal Audit function, Clarke oversaw all financial and operational audits, was instrumental in building an effective internal audit function, and reported to the Audit and Compliance Committee. Prior to MedStar, Clarke served as Managing Director in charge of the Washington D.C., Risk Management Practice for a national professional services firm, providing expert advice and services in forensic accounting, SEC reporting, and Sarbanes-Oxley Compliance. Clarke has authored numerous presentations and articles in the accounting and compliance arena, and has been featured in several publications such as Compliance Week and Practical Accountant. As a member of the Virginia Society of Certified Public Accountants, Clarke holds a Master's degree in Accounting from George Washington University and a Bachelor's Degree from Wheaton College.
PHRX Contact Info
Pharmagen, Inc.
9337 Fraser Avenue
Silver Spring, MD 20910
Website: http://www.pharmageninc.com
Phone: 204-898-8160
Email: info@pharmagenrx.com
PHRX SEC Filings
http://www.otcmarkets.com/stock/PHRX/filings
PHRX Headlines
http://finance.yahoo.com/q/h?s=PHRX+Headlines
Investigate more about PHRX @ http://www.otcmarkets.com/stock/PHRX/quote for more due diligence.
(0)
(0)Scroll down for more posts ▼